Ignite Creation Date:
2025-12-24 @ 5:24 PM
Ignite Modification Date:
2026-01-02 @ 8:42 AM
Study NCT ID:
NCT03406650
Status:
COMPLETED
Last Update Posted:
2025-05-04
First Post:
2017-12-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neoadjuvant and Adjuvant Durvalumab in Combination With Neoadjuvant Chemotherapy in Patients With Operable Urothelial Cancer.
Sponsor:
Swiss Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-05-15
Start Date Type:
ACTUAL
Primary Completion Date:
2022-02-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-01-31
Completion Date Type:
ACTUAL
First Submit Date:
2017-12-22
First Submit QC Date:
None
Study First Post Date:
2018-01-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-02
Last Update Post Date:
2025-05-04
Last Update Post Date Type:
ACTUAL